You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 16, April 28, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Chaitman and colleagues1 concluded that "ranolazine affords additional antianginal and anti-ischemic efficacy in patients with severe chronic angina who remain symptomatic while taking standard doses of atenolol, amlodipine, or diltiazem." Due to a small benefit seen in this study, as well as a significant placebo effect, we are concerned that confounding variables may have influenced these results. One such potential confounding variable not reported is the number of patients receiving statins at baseline and any changes in use throughout the study. Because the majority of patients in the trial had coronary artery disease, we assume that most would have been receiving statin therapy. In addition to their lipid-lowering ability, statins have antioxidant and anti-inflammatory properties, as well as improvements in endothelial dysfunction,2 and thus may produce similar effects as ranolazine. Statin drugs may improve symptoms of angina and improve coronary blood flow.3-4

Chaitman et al stated . . . [Full Text of this Article]

Justin S. Hooper, PharmD
Justin.Hooper@med.va.gov

Anthony J. Busti, PharmD, BCPS
Texas Tech University Health Sciences Center
Dallas



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina
and
JAMA. ;291():1959-1959.
FULL TEXT  

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina--Reply

JAMA. ;291():1959-1960.
FULL TEXT  

Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina: A Randomized Controlled Trial
, , , , , , , , and
JAMA. ;291():309-316.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.